Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time-in-range derived from self-measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant-level pooled analysis of three phase 3 LixiLan randomized controlled trials.
Haluzík M, Al-Sofiani ME, Cheng AYY, Lauand F, Melas-Melt L, Rosenstock J. Haluzík M, et al. Among authors: cheng ayy. Diabetes Obes Metab. 2024 Nov;26(11):5046-5055. doi: 10.1111/dom.15811. Epub 2024 Sep 8. Diabetes Obes Metab. 2024. PMID: 39245809 Clinical Trial.
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.
Cheng AYY, Mauricio D, Ritzel R, Al-Sofiani ME, Bailey T, Aileen Mabunay M, Bonnemaire M, Melas-Melt L, Mimouni S, Davies M. Cheng AYY, et al. Diabetes Res Clin Pract. 2024 Nov;217:111871. doi: 10.1016/j.diabres.2024.111871. Epub 2024 Sep 27. Diabetes Res Clin Pract. 2024. PMID: 39343145 Free article.
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Lingvay I, Cheng AY, Levine JA, Gomez-Valderas E, Allen SE, Ranta K, Torcello-Gómez A, Thieu VT. Lingvay I, et al. Diabetes Obes Metab. 2023 Apr;25(4):965-974. doi: 10.1111/dom.14943. Epub 2022 Dec 27. Diabetes Obes Metab. 2023. PMID: 36514843 Clinical Trial.
Diabetes and Stroke: What Are the Connections?
Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Mosenzon O, et al. J Stroke. 2023 Jan;25(1):26-38. doi: 10.5853/jos.2022.02306. Epub 2023 Jan 3. J Stroke. 2023. PMID: 36592968 Free PMC article. Review.
Shaping the future of heart health.
Cheng AYY, Zhang S, von Haehling S, Desai M. Cheng AYY, et al. Med. 2024 Sep 13;5(9):1035-1037. doi: 10.1016/j.medj.2024.08.002. Med. 2024. PMID: 39276765
64 results